CBER's Pe­ter Marks says Covid-19 shots to mir­ror flu shots: Man­u­fac­tur­ers will be in­ter­change­able

On Jan. 26, the FDA’s vac­cines ad­comm will meet to dis­cuss the fu­ture of Covid-19 boost­er shots and vari­ant strain se­lec­tion mov­ing for­ward, and CBER Di­rec­tor Pe­ter Marks yes­ter­day pre­viewed some of what will be dis­cussed in that meet­ing.

As the bi­va­lent boost­er up­take has stalled, par­tic­u­lar­ly among chil­dren, Marks is now point­ing to ways to sim­pli­fy the process.

The VRB­PAC ad­comm won’t on­ly look at what the com­po­si­tion of these Covid-19 vac­cines should be, and what’s the tim­ing for se­lect­ing new strains, but al­so how of­ten strain se­lec­tion should take place, he said, not­ing that the FDA is “try­ing to get to some sense of nor­mal­cy for how we treat vac­ci­na­tions.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER